세계 임상화학 분석기 시장은 수년 동안 역동성에 영향을 미치는 다양한 요인으로 인해 큰 성장과 변화를 겪었습니다. 임상화학 분석기는 자동화된 의료 검사 장비의 중요한 부분입니다. 이 장비는 혈액이나 소변과 같은 생물학적 샘플의 유체 샘플의 구성을 검사하고 특성을 결정합니다. 이를 위해 첨단 화학적 및 광학적인 방법을 사용합니다.
특히 신흥 경제 국가에서 정부의 혁신적인 제품 출시와 연구 개발로 인해 첨단 전자동 임상화학 분석기 및 반자동 임상화학 분석기 사용이 지속적으로 촉진되어 세계 임상화학 분석기 시장이 활성화될 것입니다. 각각의 혁신적인 화학 분석기에는 벤치탑형과 플로어 스탠딩형 두 가지 유형이 있습니다.
신흥 경제 국가들은 높은 투자, 소득 수준, 인프라 구축에 힘입어 헬스케어 분야가 빠르게 성장하고 있습니다. 일부 국가에서는 연구 활성화로 인해 임상화학 분석기 수요가 크게 증가하고 있습니다. 국가 간 기술 발전과 함께 다양한 제휴, 인수, 제품 출시가 시장 성장을 촉진하는 중요한 요인으로 작용하고 있습니다.
2023년 2월 2일, 의료기기 공급업체로 유명한 지멘스 헬티니어스와 진단 서비스 공급업체로 유명한 유니랩이 2억 유로가 넘는 다년간의 계약을 체결했습니다. 유니랩은 지멘스 헬티니어스의 첨단 기술에 투자하고 400대 이상의 과학 분석 장비를 구매하여 실험실 인프라를 더욱 업그레이드하고 고객에게 최고의 서비스를 제공할 예정입니다.
또한 2021년 2월 3일, MedTest Holdings, Inc.는 호리바 인스트루먼트(Horiba Instruments)의 어바인 본사와 호리바제작소(Horiba Manufacturing Co., Ltd.)의 교토 본사에 인수되었습니다. 이번 인수를 통해 호리바 메디칼은 포인터사이언티픽과 메드테스트의 우수한 화학제품의 혁신적인 기술을 활용하면서 체외진단 의약품 시장의 다양한 분야의 요구를 충족시킬 수 있게 되었습니다.
또한, 새로운 기술과 다양한 유형의 임상화학 분석기가 다양한 연구 목적으로 활용되고 있습니다. 만성 질환의 증가와 혁신적인 진단 제품 개발을 위한 연구의 증가는 임상화학 분석기 시장의 성장을 촉진하는 주요 요인입니다.
키트 및 소모품 비용, CPRT 비용은 임상 화학 실험실에서 구입하거나 사용하는 장비 유형에 영향을 미치는 기준 중 일부이지만 최신 임상 화학 실험실의 장비 비용은 비쌉니다.
생화학 분석기에는 많은 초기 투자가 필요하며, 최고급 모델의 경우 45,000달러에 달합니다. 높은 구매 가격으로 인해 병원과 같은 사용자는 임대 계약으로 구매할 수밖에 없어 매출이 감소하고 있습니다.
The global clinical chemistry analyzers market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. Clinical chemistry analyzers are crucial parts of automated medical laboratory equipment. These devices examine and characterize the fluid sample composition of biological samples like blood or urine. Advanced chemical or optical methods can be used to do this; however, more on that in a moment.
Government novel product launch and research, particularly in developing economies, will continue to drive utilization of advanced fully automatic clinical chemistry analyzers or semi-automatic clinical chemistry analyzers and boost the global clinical chemistry analyzers market. The respective innovative chemistry analyzers are in two modalities including bench-top and floor standing.
Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for clinical chemistry analyzers owing to the rising research. Various collaborations, acquisitions and product launches with technological advanecments among different countries will be a crucial factor driving the growth of the market.
On February 2, 2023, a multi-year arrangement with a value of more than €200 million was started by Siemens Healthineers, a renowned provider of medical equipment, and Unilabs, a renowned supplier of diagnostic services. Unilabs has invested in cutting-edge technology from Siemens Healthineers and will buy more than 400 scientific analyzers to further upgrade its laboratory infrastructure and provide its clients with unmatched service.
Additionally, on February 3, 2021, MedTest Holdings, Inc. has been purchased by the Irvine headquarters of HORIBA Instruments and the Kyoto, Japan headquarters of HORIBA, Ltd. Through this acquisition, HORIBA Medical will have the chance to serve the multidisciplinary needs of the IVD market while utilizing Pointe Scientific's and MedTest's superior Chemistry products' complimentary revolutionary technologies.
Furthermore, the rising utilization of novel technology and different types of clinical chemistry analyzers for the several research purposes. Rising chronic disorders and increasing research for innovative diagnostic product development will be a major factor driving the growth of the clinical chemistry analyzers market.
Although the cost of kits or consumables, as well as the cost of the CPRT, are some of the criteria that may affect the type of instrument to be purchased or utilized in a clinical chemistry laboratory, the cost of the equipment in modern clinical chemistry laboratories is expensive.
Biochemistry analyzers involve a large initial investment; top-of-the-line models can cost up to $45,000. Because of their high acquisition prices, users like hospitals are forced to purchase them through rental agreements, which lowers sales.
The global clinical chemistry analyzers market is segmented based on product type, modality, application, end user and region.
Fully automated chemical analyzers make it easier and more efficient to complete analytical tasks in various laboratory environments. Researchers can get evaluation results from these tools with exceptional precision. Get analysis reports in the shortest amount of time possible. A variety of diagnostic tasks are performed using fully automated chemical analyzers, including routine examination of albumin, glucose, creatinine, bilirubin, or inorganic phosphorus.
These are also employed in the execution of assays for the evaluation of lipids, therapeutic medications, illicit drugs, and more. Fully automated chemistry analyzers make it possible to do a variety of research tasks more quickly and deliver data in the shortest amount of time.
On June 8, 2023, the most recent offering from Mindray is the M1000 Chemistry with Immunoassay Integrated Solution, which combines an intelligent sample delivery module with two cutting-edge analyzers: the Chemiluminescence Immunoassay Analyzer CL-8000i and the state-of-the-art Chemistry Analyzer BS-2800M. Since its introduction, the solution has received a great deal of customer support and appreciation for its high degree of accuracy, effectiveness, and resilience, especially for the creative design and potent features of the experimental treatment system.
Due to the rising need for clinical chemistry analyzers in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for clinical chemistry analyzers.
Increasing expenditure on healthcare and rising research studies, advancement of technologies and different types of products, and increase in biopharmaceutical or biotechnology business establishment across the region are also contributing to the growth of clinical chemistry analyzers market share of this region. The market in this area is growing as people become more aware of various novel innovative products such as fully automatic clinical chemistry analyzers. The aforementioned elements further attest to North America's hegemonic position in the world.
North America continues to be a key player in the global clinical chemistry analyzers market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for clinical chemistry analyzers in the U.S. United States have been proactive in executing several initiatives or researches, stimulating clinical chemistry analyzers demand.
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global clinical chemistry analyzers market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020.
Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for clinical chemistry analyzers. Now several research studies have been initiated and companies have again started launching novel products with high efficiency. Overall, the impact of the pandemic on the global clinical chemistry analyzers market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for innovative products, like bench-top analyzers.
The major global players in the market include: F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., HORIBA Medical, Siemens Healthcare Private Limited, Hitachi High-Tech Corporation, Thermo Fisher Scientific Inc., EKF Diagnostics Holdings plc, Abbott, Mindray Medical India Pvt. Ltd. And Randox Laboratories Ltd. Among others.
The global clinical chemistry analyzers market report would provide approximately 69 tables, 66 figures and 186 Pages.
LIST NOT EXHAUSTIVE